SignatureFD’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

SignatureFD’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-309	Closed	-$67K	–	3146
2021 Q1	$67K	Sell	309 -100	-24%	-$18.8K	﹤0.01%	1044
2020 Q4	$47K	Sell	409 -100	-20%	-$11.2K	﹤0.01%	1115
2020 Q3	$50K	Hold	509	–	–	﹤0.01%	990
2020 Q2	$62K	Hold	509	–	–	﹤0.01%	875
2020 Q1	$45K	Buy	509 +279	+121%	+$29.5K	﹤0.01%	930
2019 Q4	$24K	Sell	230 -4	-2%	-$449	﹤0.01%	1218
2019 Q3	$27K	Buy	234 +154	+193%	+$23.4K	﹤0.01%	1136
2019 Q2	$14K	Buy	+80	New	+$13.8K	﹤0.01%	1322
2018 Q3	–	Sell	-76	Closed	-$11K	–	2042
2018 Q2	$11K	Buy	+76	New	+$10.8K	﹤0.01%	1376

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

SignatureFD's GWPH Position: Q2 2021 in Review

SignatureFD sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 309 shares — an estimated $67K sold.

SignatureFD first reported a position in GWPH in Q2 2018 and held it in 9 quarters. The position peaked at $67K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

SignatureFD reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
SignatureFD sold 309 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $67K.
SignatureFD first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2018 and held it in 9 quarters.
SignatureFD's GW Pharmaceuticals Plc American Depositary Shares position peaked at $67K in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on SignatureFD's 13F filing for Q2 2021, filed 26 Jul 2021.